Matches in Wikidata for { <http://www.wikidata.org/entity/Q37615959> ?p ?o ?g. }
- Q37615959 description "article científic" @default.
- Q37615959 description "article scientifique" @default.
- Q37615959 description "articolo scientifico" @default.
- Q37615959 description "artigo científico" @default.
- Q37615959 description "artículu científicu espublizáu en 2017" @default.
- Q37615959 description "bilimsel makale" @default.
- Q37615959 description "scientific article published on 31 January 2017" @default.
- Q37615959 description "vedecký článok" @default.
- Q37615959 description "vetenskaplig artikel" @default.
- Q37615959 description "videnskabelig artikel" @default.
- Q37615959 description "vědecký článek" @default.
- Q37615959 description "wetenschappelijk artikel" @default.
- Q37615959 description "wissenschaftlicher Artikel" @default.
- Q37615959 description "наукова стаття, опублікована в січні 2017" @default.
- Q37615959 description "научни чланак" @default.
- Q37615959 description "مقالة علمية نشرت في 31 يناير 2017" @default.
- Q37615959 name "Immediate salbutamol responsiveness does not predict long-term benefits of indacaterol in patients with chronic obstructive pulmonary disease." @default.
- Q37615959 name "Immediate salbutamol responsiveness does not predict long-term benefits of indacaterol in patients with chronic obstructive pulmonary disease." @default.
- Q37615959 name "Immediate salbutamol responsiveness does not predict long-term benefits of indacaterol in patients with chronic obstructive pulmonary disease." @default.
- Q37615959 type Item @default.
- Q37615959 label "Immediate salbutamol responsiveness does not predict long-term benefits of indacaterol in patients with chronic obstructive pulmonary disease." @default.
- Q37615959 label "Immediate salbutamol responsiveness does not predict long-term benefits of indacaterol in patients with chronic obstructive pulmonary disease." @default.
- Q37615959 label "Immediate salbutamol responsiveness does not predict long-term benefits of indacaterol in patients with chronic obstructive pulmonary disease." @default.
- Q37615959 prefLabel "Immediate salbutamol responsiveness does not predict long-term benefits of indacaterol in patients with chronic obstructive pulmonary disease." @default.
- Q37615959 prefLabel "Immediate salbutamol responsiveness does not predict long-term benefits of indacaterol in patients with chronic obstructive pulmonary disease." @default.
- Q37615959 prefLabel "Immediate salbutamol responsiveness does not predict long-term benefits of indacaterol in patients with chronic obstructive pulmonary disease." @default.
- Q37615959 P1433 Q37615959-05663516-9A5F-4BF8-B59A-80D3E9E2DE19 @default.
- Q37615959 P1476 Q37615959-12168186-0D66-44B0-BF56-808EA535F837 @default.
- Q37615959 P2093 Q37615959-213EC0CB-C9B9-4C37-905B-EC082F29129B @default.
- Q37615959 P2093 Q37615959-5D2BFAF8-3699-4A6F-B621-C23B52F5FD81 @default.
- Q37615959 P2093 Q37615959-9A4F17BC-B577-4B4A-8595-45A8FA482327 @default.
- Q37615959 P2093 Q37615959-D5A2F348-0B73-46F2-A97C-77C8EDD1E046 @default.
- Q37615959 P2860 Q37615959-03771F01-F31A-47BB-84AB-AC7160566E42 @default.
- Q37615959 P2860 Q37615959-0993976F-2DC8-45C2-AA22-D78F731EEA3A @default.
- Q37615959 P2860 Q37615959-1735BDCE-5E8F-4385-92EE-8F5E9C40BC40 @default.
- Q37615959 P2860 Q37615959-309EED51-AEC9-4C2F-A1BF-ED5F4C1E789E @default.
- Q37615959 P2860 Q37615959-3410AA0E-7E87-4B14-AB5D-C1901BED6054 @default.
- Q37615959 P2860 Q37615959-3A28A055-B45B-4415-944B-F607EE834095 @default.
- Q37615959 P2860 Q37615959-4D5AEAF0-CE83-4EA0-9E95-3E359975A514 @default.
- Q37615959 P2860 Q37615959-5888DD8E-30DF-40B6-A95D-AB1FB921799D @default.
- Q37615959 P2860 Q37615959-5AD331FD-ABC8-440E-B8A5-599EE3E0D418 @default.
- Q37615959 P2860 Q37615959-68C9C523-7BA0-4B9C-A129-F3EE8EC03B21 @default.
- Q37615959 P2860 Q37615959-79163518-E6B0-4D42-AA99-CB6C9B150687 @default.
- Q37615959 P2860 Q37615959-89CC768A-1452-4C31-A25A-F270DBD11DDA @default.
- Q37615959 P2860 Q37615959-9368C966-514E-491E-9D65-EEAA072AD504 @default.
- Q37615959 P2860 Q37615959-A1E84F0D-2C91-485F-BAB3-73DC63A6E44F @default.
- Q37615959 P2860 Q37615959-B084BCFD-060F-4A24-8F42-405BC683C0CD @default.
- Q37615959 P2860 Q37615959-C361D09A-E118-4672-980E-7CF946DD50F6 @default.
- Q37615959 P2860 Q37615959-C44F5404-697A-42E9-9162-B40CC3173624 @default.
- Q37615959 P2860 Q37615959-C919D5B5-919C-4DE6-88CC-5D33F3E5AA51 @default.
- Q37615959 P2860 Q37615959-CBCDE06E-7DF7-40FA-A42E-D1602F2C7D12 @default.
- Q37615959 P2860 Q37615959-D2E51FB2-4F7F-4524-B338-BE0E8CCFE4C5 @default.
- Q37615959 P2860 Q37615959-DD155BCA-5515-4DB8-98ED-B9C2EC0CB583 @default.
- Q37615959 P2860 Q37615959-E924C5A3-D120-4113-BA6C-7EC9C2534865 @default.
- Q37615959 P2860 Q37615959-F9BA5ECA-30F6-4CE6-ADE6-E75F720CE1E1 @default.
- Q37615959 P2888 Q37615959-FDADB57A-FCEC-40C7-A8DE-4F9EF1215860 @default.
- Q37615959 P304 Q37615959-17DF389F-E0CC-4596-BE07-EDC6D5D0782C @default.
- Q37615959 P31 Q37615959-E9FDCFDD-B794-4F88-B109-17FC43837BCD @default.
- Q37615959 P356 Q37615959-6084784D-CDCB-4BC7-8A97-DA494767E9BC @default.
- Q37615959 P407 Q37615959-7CAA92E4-1F86-40C0-B8C9-C1C40C79D98F @default.
- Q37615959 P433 Q37615959-A1E2DC04-AB48-44C0-960D-D3A082C150F4 @default.
- Q37615959 P478 Q37615959-7272737F-4720-4649-8922-F2FECA389FE7 @default.
- Q37615959 P50 Q37615959-043839D8-A44A-4909-B911-F13B5CAE304A @default.
- Q37615959 P50 Q37615959-915F97AA-0F5E-4BBB-B5E5-26E6BCBF6642 @default.
- Q37615959 P577 Q37615959-31BC5424-39C1-4D9B-BFDB-1166461C5A21 @default.
- Q37615959 P6179 Q37615959-22AB653F-B40B-4E4F-9F22-A19C41BD23DC @default.
- Q37615959 P698 Q37615959-7A20B71B-2555-48F8-A5C7-30A6F1682773 @default.
- Q37615959 P921 Q37615959-2F990D05-75F4-4FA8-9682-B6793C6E2E14 @default.
- Q37615959 P921 Q37615959-8C25C843-97C9-4AEC-B041-232D4238BC15 @default.
- Q37615959 P932 Q37615959-59E7C17F-C987-4E11-A4B2-961BC53B324C @default.
- Q37615959 P356 S12890-017-0372-Z @default.
- Q37615959 P698 28143447 @default.
- Q37615959 P1433 Q15755469 @default.
- Q37615959 P1476 "Immediate salbutamol responsiveness does not predict long-term benefits of indacaterol in patients with chronic obstructive pulmonary disease" @default.
- Q37615959 P2093 "Isabelle Bourdeix" @default.
- Q37615959 P2093 "Laurent Decuypère" @default.
- Q37615959 P2093 "Thierry Perez" @default.
- Q37615959 P2093 "Vincent Le Gros" @default.
- Q37615959 P2860 Q28279970 @default.
- Q37615959 P2860 Q29547365 @default.
- Q37615959 P2860 Q29614960 @default.
- Q37615959 P2860 Q34188205 @default.
- Q37615959 P2860 Q34521884 @default.
- Q37615959 P2860 Q36559591 @default.
- Q37615959 P2860 Q36740784 @default.
- Q37615959 P2860 Q37457359 @default.
- Q37615959 P2860 Q37942556 @default.
- Q37615959 P2860 Q38122178 @default.
- Q37615959 P2860 Q38181692 @default.
- Q37615959 P2860 Q38221815 @default.
- Q37615959 P2860 Q38419844 @default.
- Q37615959 P2860 Q43698089 @default.
- Q37615959 P2860 Q43955602 @default.
- Q37615959 P2860 Q46476512 @default.
- Q37615959 P2860 Q48147161 @default.
- Q37615959 P2860 Q51700354 @default.
- Q37615959 P2860 Q51700357 @default.
- Q37615959 P2860 Q57955681 @default.
- Q37615959 P2860 Q71967177 @default.
- Q37615959 P2860 Q73337858 @default.